Big Buttons

• FDA doubles down: Tirzepatide is off shortage

  ...but that doesn't mean the issue is completely settled. read more →

• A couple of state updates

  Good news from Alabama, but a problem in Massachusetts read more →

• Defending GLP-1 compounding

  The latest letters APC's been sending to oppose efforts to restrict compounding read more →

• Thumbs-up for FDA crackdown

  APC was thrilled when the FDA announced it was taking action against illegal online businesses claiming to sell “research-grade” compounds. read more →

• A PANS/PANDAS explainer

  For your patients: Information about a couple of underdiagnosed pediatric mental health conditions read more →

• What, a year?

  In the final board chair column of the year, here are our top 7 accomplishments in 2024. read more →

• “Simply not a rational approach to regulating an industry”

  This week APC offered its final (and pointed) suggestions to the California Board of Pharmacy on their proposed significant – and we would say unjustified – changes to their compounding regulations. read more →

• Get a cease and desist letter from Verrica?

  APC has heard reports from several pharmacies that have received them — here's what to know. read more →

More News

APC is releasing to its Pharmacy/Facility Members this week a Primer on Compounding Accreditations (PFM login and password required) to assist them in determining accreditations they may wish to pursue.

“Researching the various accreditations can be a real chore for pharmacy owners or their staff,” said APC’s Chief Advocacy Officer Tenille Davis. “With this document, we’re trying to make that process just a little easier for them, so they can see at a glance what each of a number of possible accreditations does and the circumstances in which having a particular one might be helpful.”